tiprankstipranks
Trending News
More News >
Alterity Therapeutics Ltd. (PRNAF)
:PRNAF
US Market

Alterity Therapeutics (PRNAF) Financial Statements

Compare
5 Followers

Alterity Therapeutics Financial Overview

Alterity Therapeutics's market cap is currently $65.12M. The company's EPS TTM is $-0.000667285; its P/E ratio is -10.83; Alterity Therapeutics is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in AUD

Alterity Therapeutics Earnings and Revenue History

Alterity Therapeutics Debt to Assets

Alterity Therapeutics Cash Flow

Alterity Therapeutics Forecast EPS vs Actual EPS